showed a trendP = 0.018
3B (i)], assessment of 4AD levels focusing on post-AI treatment showed a trend toward increased 4AD in patients who recurred when compared with patients who responded to AI therapy [ Fig. 3B (ii), t test P = 0.018, P adj . = 0.11].